反応式
[C:1]1([N:7]2[C:15]3[C:10](=[N:11][CH:12]=[CH:13][CH:14]=3)[NH:9][C:8]2=[O:16])[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.[Cl:17][CH2:18][CH:19]1[O:24][CH2:23][CH2:22][N:21]([CH2:25][C:26]2[CH:31]=[CH:30][CH:29]=[CH:28][CH:27]=2)[CH2:20]1>>[ClH:17].[CH2:25]([N:21]1[CH2:22][CH2:23][O:24][CH:19]([CH2:18][N:9]2[C:10]3=[N:11][CH:12]=[CH:13][CH:14]=[C:15]3[N:7]([C:1]3[CH:2]=[CH:3][CH:4]=[CH:5][CH:6]=3)[C:8]2=[O:16])[CH2:20]1)[C:26]1[CH:27]=[CH:28][CH:29]=[CH:30][CH:31]=1参加物
3
実験手順
The condensation of 0.1 mol of 1-phenyl-2,3-dihydroimidazo(4,5-b)pyridin-2-one and of 0.1 mol of 2-chloromethyl-4-benzyl-morpholine is carried out in accordance with the procedure of Example 1. Recrystallization of the product from a 50/25 mixture of ethyl acetate and isopropanol gives 19 g of 4-benzyl-2-(1-phenyl-2,3-dihydroimidazo (4,5-b)pyridin- 2-on-3-yl-methyl)-morpholine hydrochloride, m.p. 214° C.
後処理
- customRecrystallization of the product
- additionfrom a 50/25 mixture of ethyl acetate and isopropanol
出典と根拠
- ORDレコード
- ord-62090bd0097647f5bc9e0edb821c578a
- 出典データセット
- uspto-grants-1978_10
- 特許番号
- US04122175
関連ノート
読み込み中…